MedDataX Logo

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

NCT ID: NCT01467791

Last Updated: 2015-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2018-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Registry to follow patients with sarcoidosis associated pulmonary hypertension

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multi center registry of sarcoidosis associated pulmonary hypertension (SAPH). With this registry, the investigators will characterize the demographics, clinical course, hemodynamics, pulmonary physiology, and disease management of sarcoidosis associated pulmonary hypertension on the United States. The investigators will also compare these features to non-US sites.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcoidosis Pulmonary Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

All patients with sarcoidosis associated pulmonary hypertension

Observation

Intervention Type OTHER

Observe patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observation

Observe patients

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with sarcoidosis as defined by the ATS/WASOG statement
* Patients with pulmonary hypertension as confirmed by right heart catheterization
* Patients willing to provide written informed consent

Exclusion Criteria

* Unwillingness to provide assurance that they will complete the follow up visits for the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Cleveland Clinic

OTHER

Sponsor Role collaborator

University of Cincinnati

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Robert P Baughman

Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert P Baughman, MD

Role: STUDY_CHAIR

University of Cincinnati

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Cincinnati

Cincinnati, Ohio, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Robert P Baughman, MD

Role: CONTACT

[email protected]
513-584-5225

Rebecca Ingledue

Role: CONTACT

513-584-6252

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rebecca Ingledue

Role: primary

[email protected]
513-584-6252

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RESAPH 1

Identifier Type: -

Identifier Source: org_study_id